Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Drechsler, Christiane"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-19 z 19
    Tytuł:
    The impact of gender on the risk of cardiovascular events in older adults with advanced chronic kidney disease.
    Autorzy:
    Astley M; Amsterdam UMC location University of Amsterdam, ERA Registry, Medical Informatics, Amsterdam, the Netherlands.; Amsterdam Public Health, Health Behaviours and Chronic Diseases and Methodology, Amsterdam, the Netherlands.
    Caskey FJ; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
    Evans M; Renal Unit, Department of Clinical Intervention and Technology (CLINTEC), Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.
    Torino C; IFC-CNR, Clinical Epidemiology and Pathophysiology of Renal Diseases and Hypertension, Reggio Calabria, Italy.
    Szymczak M; Department of Nephrology and Transplantation Medicine, Wroclaw Medical University, Wroclaw, Poland.
    Drechsler C; Division of Nephrology, University Hospital of Würzburg, Würzburg, Germany.
    Pippias M; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.; North Bristol NHS Trust, Renal Unit, Bristol, UK.
    de Rooij E; Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands.
    Porto G; G.O.M., Bianchi Melacrino Morelli, Reggio Calabria, Italy.
    Stel VS; Amsterdam UMC location University of Amsterdam, ERA Registry, Medical Informatics, Amsterdam, the Netherlands.; Amsterdam Public Health Research Institute, Quality of Care, Amsterdam, the Netherlands.
    Dekker FW; Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands.
    Wanner C; Division of Nephrology, University Hospital of Würzburg, Würzburg, Germany.
    Jager KJ; Amsterdam UMC location University of Amsterdam, ERA Registry, Medical Informatics, Amsterdam, the Netherlands.; Amsterdam Public Health Research Institute, Quality of Care, Amsterdam, the Netherlands.
    Chesnaye NC; Amsterdam UMC location University of Amsterdam, ERA Registry, Medical Informatics, Amsterdam, the Netherlands.; Amsterdam Public Health Research Institute, Quality of Care, Amsterdam, the Netherlands.
    Pokaż więcej
    Corporate Authors:
    EQUAL study investigators
    Źródło:
    Clinical kidney journal [Clin Kidney J] 2023 Apr 19; Vol. 16 (12), pp. 2396-2404. Date of Electronic Publication: 2023 Apr 19 (Print Publication: 2023).
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Soluble suppression of tumorigenesis-2 is a strong predictor of all-cause, cardiovascular and infection-related mortality risk in haemodialysis patients with diabetes mellitus.
    Autorzy:
    Hammer F; Department of Internal Medicine B, Division of Cardiology, University Medicine Greifswald, Greifswald, Germany.; Department of Internal Medicine I, Division of Cardiology, University Hospital Würzburg, Würzburg, Germany.; Comprehensive Heart Failure Centre, University Hospital Würzburg, Würzburg, Germany.
    Genser B; Center for Preventive Medicine and Digital Health Baden-Württemberg, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.; BGStats Consulting, Vienna, Austria.
    Dieplinger B; Department of Laboratory Medicine, Konventhospital Barmherzige Brueder Linz and Ordensklinikum Linz Barmherzige Schwestern, Linz, Austria.
    Egger M; Department of Laboratory Medicine, Konventhospital Barmherzige Brueder Linz and Ordensklinikum Linz Barmherzige Schwestern, Linz, Austria.
    Müller T; Department of Laboratory Diagnostics, Hospital of Gmunden, Gmunden, Austria.
    Drechsler C; Department of Medicine I, Division of Nephrology, University Hospital Würzburg, Würzburg, Germany.
    März W; Synlab Akademie für ärztliche Fortbildung, Synlab Services GmbH, Mannheim, Germany.
    Störk S; Department of Internal Medicine I, Division of Cardiology, University Hospital Würzburg, Würzburg, Germany.; Comprehensive Heart Failure Centre, University Hospital Würzburg, Würzburg, Germany.
    Wanner C; Comprehensive Heart Failure Centre, University Hospital Würzburg, Würzburg, Germany.; Department of Medicine I, Division of Nephrology, University Hospital Würzburg, Würzburg, Germany.
    Krane V; Comprehensive Heart Failure Centre, University Hospital Würzburg, Würzburg, Germany.; Department of Medicine I, Division of Nephrology, University Hospital Würzburg, Würzburg, Germany.
    Pokaż więcej
    Źródło:
    Clinical kidney journal [Clin Kidney J] 2022 May 18; Vol. 15 (10), pp. 1915-1923. Date of Electronic Publication: 2022 May 18 (Print Publication: 2022).
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Converting from face-to-face to postal follow-up and its effects on participant retention, response rates and errors: lessons from the EQUAL study in the UK.
    Autorzy:
    Gates E; Centre for Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK. .; Southmead Hospital, North Bristol NHS Trust, Bristol, UK. .
    Hole B; Centre for Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.; Southmead Hospital, North Bristol NHS Trust, Bristol, UK.; UK Renal Registry, Southmead Hospital, Bristol, UK.
    Hayward S; Centre for Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.; Southmead Hospital, North Bristol NHS Trust, Bristol, UK.; UK Renal Registry, Southmead Hospital, Bristol, UK.
    Chesnaye NC; ERA-EDTA Registry, Department of Medical Informatics, Academic Medical Center, University of Amsterdam, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands.
    Meuleman Y; Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.
    Dekker FW; Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.
    Evans M; Renal Unit, Department of Clinical Intervention and technology (CLINTEC), Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.
    Heimburger O; Renal Unit, Department of Clinical Intervention and technology (CLINTEC), Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.
    Torino C; Institute of Clinical Physiology, National Research Council, Reggio Calabria, Italy.
    Porto G; GOM Bianchi Melacrino Morelli, Reggio Calabria, Italy.
    Szymczak M; Department of Nephrology and Transplantation Medicine, Wroclaw Medical University, Wroclaw, Poland.
    Drechsler C; Division of Nephrology, University Hospital of Wurzburg, Wurzburg, Germany.
    Wanner C; Division of Nephrology, University Hospital of Wurzburg, Wurzburg, Germany.
    Jager KJ; ERA-EDTA Registry, Department of Medical Informatics, Academic Medical Center, University of Amsterdam, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands.
    Roderick P; School of Primary Care Population Sciences and Medical Education, Faculty of Medicine, University of Southampton, Southampton, UK.
    Caskey F; Centre for Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.; Southmead Hospital, North Bristol NHS Trust, Bristol, UK.
    Pokaż więcej
    Corporate Authors:
    EQUAL investigators
    Źródło:
    BMC medical research methodology [BMC Med Res Methodol] 2022 Feb 11; Vol. 22 (1), pp. 44. Date of Electronic Publication: 2022 Feb 11.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    COVID-19*
    Pandemics*
    Follow-Up Studies ; Humans ; Prospective Studies ; SARS-CoV-2 ; United Kingdom/epidemiology
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    The relationship between uremic toxins and symptoms in older men and women with advanced chronic kidney disease.
    Autorzy:
    Massy ZA; Centre for Research in Epidemiology and Population Health, INSERM UMRS 1018, Team5, Paris, France.
    Chesnaye NC; ERA Registry, Department of Medical Informatics, Academic Medical Center, University of Amsterdam, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands.
    Larabi IA; Laboratory of Pharmacology and Toxicology, CHU, Raymond Poincare, Garches, and INSERM U‑1173, UFR des Sciences de la Santé Simone Veil, Montigny le Bretonneux, Université de Versailles-Saint-Quentin-en-Yvelines, Versailles, France.
    Dekker FW; Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.
    Evans M; Renal Unit, Department of Clinical Intervention and Technology, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.
    Caskey FJ; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
    Torino C; IFC-CNR, Clinical Epidemiology and Pathophysiology of Renal Diseases and Hypertension, Reggio Calabria, Italy.
    Porto G; G.O.M.,  Bianchi Melacrino Morelli, Reggio Calabria, Italy.
    Szymczak M; Department of Nephrology and Transplantation Medicine, Wroclaw Medical University, Wroclaw, Poland.
    Drechsler C; Division of Nephrology, University Hospital of Würzburg, Würzburg, Germany.
    Wanner C; Division of Nephrology, University Hospital of Würzburg, Würzburg, Germany.
    Jager KJ; ERA Registry, Department of Medical Informatics, Academic Medical Center, University of Amsterdam, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands.
    Alvarez JC; Laboratory of Pharmacology and Toxicology, CHU, Raymond Poincare, Garches, and INSERM U‑1173, UFR des Sciences de la Santé Simone Veil, Montigny le Bretonneux, Université de Versailles-Saint-Quentin-en-Yvelines, Versailles, France.
    Pokaż więcej
    Corporate Authors:
    EQUAL study investigators
    Źródło:
    Clinical kidney journal [Clin Kidney J] 2021 Dec 10; Vol. 15 (4), pp. 798-807. Date of Electronic Publication: 2021 Dec 10 (Print Publication: 2022).
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Clinical hemocompatibility of double-filtration lipoprotein apheresis comparing polyethersulfone and ethylene-vinyl alcohol copolymer membranes.
    Autorzy:
    Krieter DH; Division of Nephrology, Department of Medicine I, University Hospital Würzburg, Würzburg, Germany.
    Jeyaseelan J; Division of Nephrology, Department of Medicine I, University Hospital Würzburg, Würzburg, Germany.
    Rüth M; eXcorLab GmbH, Obernburg, Germany.
    Lemke HD; eXcorLab GmbH, Obernburg, Germany.
    Wanner C; Division of Nephrology, Department of Medicine I, University Hospital Würzburg, Würzburg, Germany.
    Drechsler C; Division of Nephrology, Department of Medicine I, University Hospital Würzburg, Würzburg, Germany.
    Pokaż więcej
    Źródło:
    Artificial organs [Artif Organs] 2021 Sep; Vol. 45 (9), pp. 1104-1113. Date of Electronic Publication: 2021 May 04.
    Typ publikacji:
    Comparative Study; Journal Article; Randomized Controlled Trial
    MeSH Terms:
    Membranes, Artificial*
    Blood Component Removal/*instrumentation
    Hyperlipidemias/*therapy
    Lipoproteins/*metabolism
    Polymers/*chemistry
    Polyvinyls/*chemistry
    Sulfones/*chemistry
    Adult ; Aged ; Biocompatible Materials ; Blood Cell Count ; Cross-Over Studies ; Female ; Humans ; Male ; Middle Aged ; Prospective Studies
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Risk factors for retinopathy in hemodialysis patients with type 2 diabetes mellitus.
    Autorzy:
    Müller M; Department of Ophthalmology, Goethe-University, Theodor Stern Kai 7, 60590, Frankfurt am Main, Germany. .
    Schönfeld CL; Herzog Carl Theodor Eye Clinic, Munich, Germany.
    Grammer T; Mannheim Institute of Public Health, Social and Preventive Medicine, Medical Faculty Mannheim, University of Heidelberg, Heidelberg, Germany.
    Krane V; Division of Nephrology, Department of Medicine, University Clinic Würzburg, Würzburg, Germany.
    Drechsler C; Division of Nephrology, Department of Medicine, University Clinic Würzburg, Würzburg, Germany.
    Genser B; Mannheim Institute of Public Health, Social and Preventive Medicine, Medical Faculty Mannheim, University of Heidelberg, Heidelberg, Germany.
    Kohnen T; Department of Ophthalmology, Goethe-University, Theodor Stern Kai 7, 60590, Frankfurt am Main, Germany.
    Wanner C; Division of Nephrology, Department of Medicine, University Clinic Würzburg, Würzburg, Germany.
    März W; Mannheim Institute of Public Health, Social and Preventive Medicine, Medical Faculty Mannheim, University of Heidelberg, Heidelberg, Germany.; Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria.; Synlab Academy, Synlab Services GmbH, Mannheim, Germany.
    Pokaż więcej
    Źródło:
    Scientific reports [Sci Rep] 2020 Aug 25; Vol. 10 (1), pp. 14158. Date of Electronic Publication: 2020 Aug 25.
    Typ publikacji:
    Journal Article; Observational Study; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Renal Dialysis*
    Diabetes Mellitus, Type 2/*complications
    Diabetic Nephropathies/*etiology
    Diabetic Retinopathy/*etiology
    Aged ; Aged, 80 and over ; Apolipoproteins/blood ; Blindness/epidemiology ; Blindness/etiology ; Blood Glucose/analysis ; Body Mass Index ; Comorbidity ; Coronary Disease/epidemiology ; Cross-Sectional Studies ; Diabetes Mellitus, Type 2/blood ; Diabetic Nephropathies/epidemiology ; Diabetic Retinopathy/epidemiology ; Female ; Glycated Hemoglobin/analysis ; Humans ; Hyperlipidemias/epidemiology ; Hypertension/epidemiology ; Inflammation/epidemiology ; Lipids/blood ; Male ; Middle Aged ; Prevalence ; Risk Factors ; Smoking/epidemiology
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Reduced ADAMTS13 levels in patients with acute and chronic cerebrovascular disease.
    Autorzy:
    Denorme F; Laboratory for Thrombosis Research, KU Leuven Campus Kulak Kortrijk, Kortrijk, Belgium.
    Kraft P; Department of Neurology, University Hospital of Würzburg, Würzburg, Germany.
    Pareyn I; Laboratory for Thrombosis Research, KU Leuven Campus Kulak Kortrijk, Kortrijk, Belgium.
    Drechsler C; Department of Internal Medicine, University Hospital of Würzburg, Würzburg, Germany.
    Deckmyn H; Laboratory for Thrombosis Research, KU Leuven Campus Kulak Kortrijk, Kortrijk, Belgium.
    Vanhoorelbeke K; Laboratory for Thrombosis Research, KU Leuven Campus Kulak Kortrijk, Kortrijk, Belgium.
    Kleinschnitz C; Department of Neurology, University Hospital Essen, Essen, Germany.
    De Meyer SF; Laboratory for Thrombosis Research, KU Leuven Campus Kulak Kortrijk, Kortrijk, Belgium.
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2017 Jun 07; Vol. 12 (6), pp. e0179258. Date of Electronic Publication: 2017 Jun 07 (Print Publication: 2017).
    Typ publikacji:
    Journal Article
    MeSH Terms:
    ADAMTS13 Protein/*blood
    Cerebrovascular Disorders/*blood
    Stroke/*blood
    von Willebrand Factor/*metabolism
    Acute Disease/epidemiology ; Adult ; Aged ; Aged, 80 and over ; Cerebrovascular Disorders/epidemiology ; Cerebrovascular Disorders/physiopathology ; Chronic Disease/epidemiology ; Female ; Humans ; Male ; Middle Aged ; Risk Factors ; Stroke/epidemiology ; Stroke/physiopathology ; Thrombosis/blood ; Thrombosis/physiopathology
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Characterization of Peripheral Immune Cell Subsets in Patients with Acute and Chronic Cerebrovascular Disease: A Case-Control Study.
    Autorzy:
    Kraft P; Department of Neurology, University Hospital Würzburg, 97080 Würzburg, Germany. kraft_.
    Drechsler C; Department of Internal Medicine, University Hospital Würzburg, 97080 Würzburg, Germany. Drechsler_.
    Schuhmann MK; Department of Neurology, University Hospital Würzburg, 97080 Würzburg, Germany. schuhmann_.
    Gunreben I; Department of Neurology, University Hospital Würzburg, 97080 Würzburg, Germany. Gunreben_.
    Kleinschnitz C; Department of Neurology, University Hospital Würzburg, 97080 Würzburg, Germany. kleinschni_.
    Pokaż więcej
    Źródło:
    International journal of molecular sciences [Int J Mol Sci] 2015 Oct 23; Vol. 16 (10), pp. 25433-49. Date of Electronic Publication: 2015 Oct 23.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Cerebrovascular Disorders/*blood
    Lymphocyte Subsets/*immunology
    Aged ; Aged, 80 and over ; Biomarkers/blood ; Case-Control Studies ; Cerebrovascular Disorders/immunology ; Chronic Disease ; Female ; Humans ; Lymphocyte Subsets/cytology ; Male
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND).
    Autorzy:
    Iyengar SK; Department of Epidemiology & Biostatistics, Case Western Reserve University, Cleveland, Ohio, United States of America.
    Sedor JR; Departments of Medicine, Case Western Reserve University, Cleveland, Ohio, United States of America; Departments of Physiology and Biophysics, Case Western Reserve University, Cleveland, Ohio, United States of America.
    Freedman BI; Department of Internal Medicine, Section on Nephrology, Wake Forest School of Medicine, Winston-Salem, North Carolina, United States of America.
    Kao WH; Department of Epidemiology and Medicine, John Hopkins University, Baltimore, Maryland, United States of America.
    Kretzler M; Department of Internal Medicine/Nephrology, University of Michigan, Ann Arbor, Michigan, United States of America.
    Keller BJ; Department of Internal Medicine/Nephrology, University of Michigan, Ann Arbor, Michigan, United States of America.
    Abboud HE; Department of Medicine/Nephrology, The University of Texas Health Science Center, San Antonio, Texas, United States of America.
    Adler SG; Department of Medicine, Division of Nephrology and Hypertension, Harbor-UCLA Medical Center, Torrance, California, United States of America.
    Best LG; Missouri Breaks Industries Research, Timber Lake, South Dakota, United States of America.
    Bowden DW; Department of Biochemistry, Center for Human Genomics, Wake Forest School of Medicine, Winston-Salem, North Carolina, United States of America.
    Burlock A; Department of Internal Medicine/Nephrology, University of Michigan, Ann Arbor, Michigan, United States of America.
    Chen YD; The Institute for Translational Genomics and Population Sciences, Harbor-UCLA Medical Center, Torrance, California, United States of America.
    Cole SA; Department of Genetics, Texas Biomedical Research Institute, San Antonio, Texas, United States of America.
    Comeau ME; Center for Public Health Genomics and Department of Biostatistical Sciences, Division of Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, United States of America.
    Curtis JM; National Institutes of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, Arizona, United States of America.
    Divers J; Center for Public Health Genomics and Department of Biostatistical Sciences, Division of Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, United States of America.
    Drechsler C; University Hospital Würzburg, Renal Division and Comprehensive Heart Failure Center, Würzburg, Germany.
    Duggirala R; Department of Genetics, Texas Biomedical Research Institute, San Antonio, Texas, United States of America.
    Elston RC; Department of Epidemiology & Biostatistics, Case Western Reserve University, Cleveland, Ohio, United States of America.
    Guo X; The Institute for Translational Genomics and Population Sciences, Harbor-UCLA Medical Center, Torrance, California, United States of America.
    Huang H; Department of Ecology and Evolutionary Biology, University of Michigan, Ann Arbor, Michigan, United States of America.
    Hoffmann MM; Department of Clinical Chemistry, University Medical Center, Freiburg, Germany.
    Howard BV; MedStar Health Research Institute, Hyattsville, Maryland, United States of America.
    Ipp E; Department of Medicine, Section of Diabetes and Metabolism, Harbor-UCLA Medical Center, Torrance, California, United States of America.
    Kimmel PL; Division of Kidney, Urologic, and Hematologic Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland, United States of America.
    Klag MJ; Johns Hopkins Bloomberg School of Public Health, Johns Hopkins School of Medicine, Baltimore, Maryland, United States of America.
    Knowler WC; National Institutes of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, Arizona, United States of America.
    Kohn OF; Department of Medicine, University of Chicago Medicine, Chicago, Illinois, United States of America.
    Leak TS; Department of Internal Medicine/Nephrology, University of Michigan, Ann Arbor, Michigan, United States of America.
    Leehey DJ; Department of Medicine, Loyola School of Medicine, Maywood, Illinois, United States of America.
    Li M; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
    Malhotra A; National Institutes of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, Arizona, United States of America.
    März W; Heidelberg University and Synlab Academy, University of Graz, Graz, Austria.
    Nair V; Department of Internal Medicine/Nephrology, University of Michigan, Ann Arbor, Michigan, United States of America.
    Nelson RG; National Institutes of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, Arizona, United States of America.
    Nicholas SB; Department of Medicine, University of California, Los Angeles, Los Angeles, California, United States of America.
    O'Brien SJ; Theodosius Dobzhansky Center for Genome Bioinformatics, St. Petersburg, Russia, and Oceanographic Center, Nova Southeastern University, Ft. Lauderdale, Florida, United States of America.
    Pahl MV; Department of Medicine, University of California, Irvine, Irvine, California, United States of America.
    Parekh RS; Departments of Paediatrics and Medicine, Hospital for Sick Children, University Health Network and the University of Toronto, Toronto, Ontario, Canada.
    Pezzolesi MG; Department of Medicine, Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts, United States of America.
    Rasooly RS; National Institute of Diabetes and Digestive Disease, National Institutes of Health, Bethesda, Maryland, United States of America.
    Rotimi CN; Center for Research on Genomics and Global Health, Bethesda, Maryland, United States of America.
    Rotter JI; The Institute for Translational Genomics and Population Sciences, Harbor-UCLA Medical Center, Torrance, California, United States of America.
    Schelling JR; Departments of Medicine, Case Western Reserve University, Cleveland, Ohio, United States of America.
    Seldin MF; Department of Biochemistry and Molecular Medicine, UC Davis School of Medicine, Davis, California, United States of America.
    Shah VO; Department of Biochemistry & Molecular Biology, University of New Mexico, Albuquerque, New Mexico, United States of America.
    Smiles AM; Joslin Diabetes Center, Section on Genetics and Epidemiology, Boston, Massachusetts, United States of America.
    Smith MW; National Human Genome Research Institute, Rockville, Maryland, United States of America.
    Taylor KD; The Institute for Translational Genomics and Population Sciences, Harbor-UCLA Medical Center, Torrance, California, United States of America.
    Thameem F; Department of Medicine, The University of Texas Health Science Center, San Antonio, Texas, United States of America.
    Thornley-Brown DP; Nephrology, University of Alabama Birmingham, Birmingham, Alabama, United States of America.
    Truitt BJ; Department of Epidemiology & Biostatistics, Case Western Reserve University, Cleveland, Ohio, United States of America.
    Wanner C; Department of Medicine, Division of Nephrology, University Hospital Würzburg, Würzburg, Germany.
    Weil EJ; National Institutes of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, Arizona, United States of America.
    Winkler CA; Center for Cancer Research, National Cancer Institute, Frederick, Maryland, United States of America.
    Zager PG; Department of Internal Medicine, University of New Mexico, Albuquerque, New Mexico, United States of America.
    Igo RP Jr; Department of Epidemiology & Biostatistics, Case Western Reserve University, Cleveland, Ohio, United States of America.
    Hanson RL; National Institutes of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, Arizona, United States of America.
    Langefeld CD; The Institute for Translational Genomics and Population Sciences, Harbor-UCLA Medical Center, Torrance, California, United States of America.
    Pokaż więcej
    Corporate Authors:
    Family Investigation of Nephropathy and Diabetes (FIND)
    Źródło:
    PLoS genetics [PLoS Genet] 2015 Aug 25; Vol. 11 (8), pp. e1005352. Date of Electronic Publication: 2015 Aug 25 (Print Publication: 2015).
    Typ publikacji:
    Journal Article; Meta-Analysis; Research Support, N.I.H., Extramural
    MeSH Terms:
    Diabetes Mellitus, Type 2/*genetics
    Diabetic Nephropathies/*genetics
    Black or African American/genetics ; Diabetes Mellitus, Type 2/complications ; Diabetic Nephropathies/ethnology ; Genetic Predisposition to Disease ; Genome-Wide Association Study ; Hispanic or Latino/genetics ; Humans ; Indians, North American/genetics ; RNA-Binding Proteins/genetics ; United States ; White People/genetics
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Effect of High-Flux Dialysis on Circulating FGF-23 Levels in End-Stage Renal Disease Patients: Results from a Randomized Trial.
    Autorzy:
    Schneider A; Department of Medicine, Division of Nephrology, University Hospital, Würzburg, Germany.
    Schneider MP; Department of Nephrology and Hypertension, University Hospital, Erlangen-Nürnberg, Germany.
    Krieter DH; Department of Medicine, Division of Nephrology, University Hospital, Würzburg, Germany.
    Genser B; Mannheim Institute of Public Health, Social and Preventive Medicine, Medical Faculty, Mannheim, Germany; BGStats Consulting, Vienna, Austria.
    Scharnagl H; Medical University of Graz, Clinical Institute of Medical and Chemical Laboratory Diagnostics, Graz, Austria.
    Stojakovic T; Medical University of Graz, Clinical Institute of Medical and Chemical Laboratory Diagnostics, Graz, Austria.
    Wanner C; Department of Medicine, Division of Nephrology, University Hospital, Würzburg, Germany.
    Drechsler C; Department of Medicine, Division of Nephrology, University Hospital, Würzburg, Germany.
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2015 May 29; Vol. 10 (5), pp. e0128079. Date of Electronic Publication: 2015 May 29 (Print Publication: 2015).
    Typ publikacji:
    Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Fibroblast Growth Factors/*blood
    Kidney Failure, Chronic/*therapy
    Renal Dialysis/*methods
    Aged ; Bone Density ; Female ; Fibroblast Growth Factor-23 ; Humans ; Kidney Failure, Chronic/blood ; Male ; Middle Aged ; Parathyroid Hormone/blood ; Phosphates/blood ; Regression Analysis ; Treatment Outcome
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Case-control study of platelet glycoprotein receptor Ib and IIb/IIIa expression in patients with acute and chronic cerebrovascular disease.
    Autorzy:
    Kraft P; Department of Neurology, University Hospital Würzburg, Würzburg, Germany; Institute of Clinical Epidemiology and Biometry, Comprehensive Heart Failure Center, University of Würzburg, Würzburg, Germany.
    Drechsler C; Department of Internal Medicine, University Hospital Würzburg, Würzburg, Germany.
    Gunreben I; Department of Neurology, University Hospital Würzburg, Würzburg, Germany.
    Heuschmann PU; Clinical Trial Center, University Hospital Würzburg, Würzburg, Germany; Institute of Clinical Epidemiology and Biometry, Comprehensive Heart Failure Center, University of Würzburg, Würzburg, Germany.
    Kleinschnitz C; Department of Neurology, University Hospital Würzburg, Würzburg, Germany.
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2015 Mar 06; Vol. 10 (3), pp. e0119810. Date of Electronic Publication: 2015 Mar 06 (Print Publication: 2015).
    Typ publikacji:
    Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Gene Expression Regulation*
    Blood Platelets/*metabolism
    Brain Ischemia/*metabolism
    Platelet Glycoprotein GPIIb-IIIa Complex/*biosynthesis
    Platelet Glycoprotein GPIb-IX Complex/*biosynthesis
    Stroke/*metabolism
    Aged ; Aged, 80 and over ; Case-Control Studies ; Female ; Humans ; Male ; Middle Aged
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Von Willebrand factor regulation in patients with acute and chronic cerebrovascular disease: a pilot, case-control study.
    Autorzy:
    Kraft P; Department of Neurology, University Hospital Würzburg, Würzburg, Germany; Institute of Clinical Epidemiology and Biometry, Comprehensive Heart Failure Center, University of Würzburg, Würzburg, Germany.
    Drechsler C; Department of Internal Medicine, University Hospital Würzburg, Würzburg, Germany.
    Gunreben I; Department of Neurology, University Hospital Würzburg, Würzburg, Germany.
    Nieswandt B; Rudolf Virchow Center for Experimental Biomedicine, University of Würzburg, Würzburg, Germany.
    Stoll G; Department of Neurology, University Hospital Würzburg, Würzburg, Germany.
    Heuschmann PU; The Clinical Trial Center, University Hospital Würzburg, Würzburg, Germany; Institute of Clinical Epidemiology and Biometry, Comprehensive Heart Failure Center, University of Würzburg, Würzburg, Germany.
    Kleinschnitz C; Department of Neurology, University Hospital Würzburg, Würzburg, Germany.
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2014 Jun 17; Vol. 9 (6), pp. e99851. Date of Electronic Publication: 2014 Jun 17 (Print Publication: 2014).
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Cerebrovascular Disorders/*blood
    von Willebrand Factor/*metabolism
    Aged ; Aged, 80 and over ; Analysis of Variance ; Biomarkers/blood ; Case-Control Studies ; Chronic Disease ; Female ; Humans ; Ischemic Attack, Transient/blood ; Male ; Middle Aged ; Multivariate Analysis ; Pilot Projects ; Risk Factors
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Single nucleotide variants in the protein C pathway and mortality in dialysis patients.
    Autorzy:
    Ocak G; Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.
    Drechsler C; Department of Medicine, Division of Nephrology, University Hospital, Würzburg, Germany; Comprehensive Heart Failure Center, University of Wuerzburg, Wuerzburg, Germany; Institute of Clinical Epidemiology and Biometry, University of Wuerzburg, Wuerzburg, Germany.
    Vossen CY; Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.
    Vos HL; Department of Thrombosis and Haemostasis, Leiden University Medical Center, Leiden, The Netherlands; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands.
    Rosendaal FR; Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands; Department of Thrombosis and Haemostasis, Leiden University Medical Center, Leiden, The Netherlands; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands.
    Reitsma PH; Department of Thrombosis and Haemostasis, Leiden University Medical Center, Leiden, The Netherlands; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands.
    Hoffmann MM; Institute of Clinical Chemistry and Laboratory Medicine, University Medical Center, Freiburg, Germany.
    März W; Department of Public Health, Social and Preventive Medicine, University of Heidelberg, Mannheim, Germany.
    Ouwehand WH; Department of Hematology, University of Cambridge and National Health Service Blood and Transplant, Cambridge, United Kingdom; Department of Human Genetics, Wellcome Trust Sanger Institute, Cambridge, United Kingdom.
    Krediet RT; Department of Nephrology, Academic Medical Center, Amsterdam, The Netherlands.
    Boeschoten EW; Hans Mak Institute, Naarden, The Netherlands.
    Dekker FW; Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.
    Wanner C; Department of Medicine, Division of Nephrology, University Hospital, Würzburg, Germany; Comprehensive Heart Failure Center, University of Wuerzburg, Wuerzburg, Germany.
    Verduijn M; Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2014 May 09; Vol. 9 (5), pp. e97251. Date of Electronic Publication: 2014 May 09 (Print Publication: 2014).
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Factor V/*genetics
    Polymorphism, Single Nucleotide/*genetics
    Protein C/*genetics
    Renal Dialysis/*mortality
    Signal Transduction/*genetics
    Antigens, CD/genetics ; Endothelial Protein C Receptor ; Germany ; Humans ; Netherlands ; Receptors, Cell Surface/genetics ; Thrombomodulin/genetics
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Homoarginine and mortality in an older population: the Hoorn study.
    Autorzy:
    Pilz S; Department of Epidemiology and Biostatistics, EMGO Institute for Health and Care Research, VU University Medical Centre, Amsterdam, the Netherlands; Division of Endocrinology and Metabolism, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
    Teerlink T
    Scheffer PG
    Meinitzer A
    Rutters F
    Tomaschitz A
    Drechsler C
    Kienreich K
    Nijpels G
    Stehouwer CD
    März W
    Dekker JM
    Pokaż więcej
    Źródło:
    European journal of clinical investigation [Eur J Clin Invest] 2014 Feb; Vol. 44 (2), pp. 200-8. Date of Electronic Publication: 2013 Dec 14.
    Typ publikacji:
    Journal Article; Observational Study
    MeSH Terms:
    Cardiovascular Diseases/*mortality
    Homoarginine/*deficiency
    Age Factors ; Aged ; Cardiovascular Diseases/blood ; Epidemiologic Methods ; Female ; Humans ; Male ; Middle Aged ; Netherlands/epidemiology
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Homoarginine and progression of chronic kidney disease: results from the Mild to Moderate Kidney Disease Study.
    Autorzy:
    Drechsler C; Division of Nephrology, Department of Medicine, University of Würzburg, Würzburg, Germany.
    Kollerits B
    Meinitzer A
    März W
    Ritz E
    König P
    Neyer U
    Pilz S
    Wanner C
    Kronenberg F
    Pokaż więcej
    Corporate Authors:
    MMKD Study Group
    Źródło:
    PloS one [PLoS One] 2013 May 15; Vol. 8 (5), pp. e63560. Date of Electronic Publication: 2013 May 15 (Print Publication: 2013).
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Homoarginine/*blood
    Kidney Failure, Chronic/*blood
    Adult ; Disease Progression ; Female ; Glomerular Filtration Rate ; Humans ; Kidney Failure, Chronic/physiopathology ; Male ; Middle Aged ; Prospective Studies ; Severity of Illness Index
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Lipoprotein-associated phospholipase A2 and outcome in patients with type 2 diabetes on haemodialysis.
    Autorzy:
    Winkler K; Department of Clinical Chemistry, University Medical Center Freiburg, Hugstetter Strasse 55, Freiburg, Germany. />Hoffmann MM
    Krane V
    Drechsler C
    Wanner C
    Pokaż więcej
    Corporate Authors:
    German Diabetes and Dialysis Study Investigators
    Źródło:
    European journal of clinical investigation [Eur J Clin Invest] 2012 Jul; Vol. 42 (7), pp. 693-701. Date of Electronic Publication: 2011 Dec 29.
    Typ publikacji:
    Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
    MeSH Terms:
    1-Alkyl-2-acetylglycerophosphocholine Esterase/*blood
    Coronary Artery Disease/*drug therapy
    Diabetes Mellitus, Type 2/*therapy
    Heptanoic Acids/*therapeutic use
    Hydroxymethylglutaryl-CoA Reductase Inhibitors/*therapeutic use
    Pyrroles/*therapeutic use
    Aged ; Area Under Curve ; Atorvastatin ; Coronary Artery Disease/enzymology ; Coronary Artery Disease/mortality ; Diabetes Mellitus, Type 2/mortality ; Double-Blind Method ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Predictive Value of Tests ; Renal Dialysis ; Risk Factors
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Homoarginine, heart failure, and sudden cardiac death in haemodialysis patients.
    Autorzy:
    Drechsler C; Department of Internal Medicine 1, Division of Nephrology, University of Würzburg, Würzburg, Germany. c.drechsler@gmx.net
    Meinitzer A
    Pilz S
    Krane V
    Tomaschitz A
    Ritz E
    März W
    Wanner C
    Pokaż więcej
    Źródło:
    European journal of heart failure [Eur J Heart Fail] 2011 Aug; Vol. 13 (8), pp. 852-9.
    Typ publikacji:
    Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Death, Sudden, Cardiac/*epidemiology
    Heart Failure/*mortality
    Homoarginine/*deficiency
    Renal Dialysis/*mortality
    Aged ; Biomarkers/blood ; Female ; Heart Failure/blood ; Homoarginine/blood ; Humans ; Kidney Failure, Chronic/therapy ; Male ; Middle Aged ; Prospective Studies ; Risk Factors
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Understanding competing risks: a simulation point of view.
    Autorzy:
    Allignol A; Freiburg Center for Data Analysis and Modeling, University of Freiburg, Germany. />Schumacher M
    Wanner C
    Drechsler C
    Beyersmann J
    Pokaż więcej
    Źródło:
    BMC medical research methodology [BMC Med Res Methodol] 2011 Jun 03; Vol. 11, pp. 86. Date of Electronic Publication: 2011 Jun 03.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Survival Analysis*
    Algorithms ; Computer Simulation ; Confidence Intervals ; Humans ; Proportional Hazards Models ; Risk
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    C-reactive protein and uremia.
    Autorzy:
    Wanner C; Division of Nephrology, Department of Medicine, University of Wuerzburg, Würzburg, Germany. wanner_ />Drechsler C
    Krane V
    Pokaż więcej
    Źródło:
    Seminars in dialysis [Semin Dial] 2009 Jul-Aug; Vol. 22 (4), pp. 438-41.
    Typ publikacji:
    Journal Article; Review
    MeSH Terms:
    C-Reactive Protein/*metabolism
    Cardiovascular Diseases/*etiology
    Uremia/*blood
    Uremia/*complications
    Cardiovascular Diseases/blood ; Humans ; Predictive Value of Tests ; Risk Factors
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
      Wyświetlanie 1-19 z 19

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies